Jump Financial LLC Makes New Investment in Clover Health Investments, Corp. (NASDAQ:CLOV)

Jump Financial LLC acquired a new stake in Clover Health Investments, Corp. (NASDAQ:CLOVFree Report) during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 131,200 shares of the company’s stock, valued at approximately $125,000.

Other institutional investors also recently modified their holdings of the company. Commonwealth Equity Services LLC raised its holdings in Clover Health Investments by 6.4% during the third quarter. Commonwealth Equity Services LLC now owns 191,797 shares of the company’s stock worth $207,000 after buying an additional 11,588 shares during the last quarter. Allspring Global Investments Holdings LLC acquired a new position in Clover Health Investments during the third quarter worth $26,000. Swiss National Bank raised its holdings in Clover Health Investments by 1.6% during the third quarter. Swiss National Bank now owns 782,200 shares of the company’s stock worth $845,000 after buying an additional 12,400 shares during the last quarter. Vanguard Personalized Indexing Management LLC acquired a new position in Clover Health Investments during the third quarter worth $25,000. Finally, Citigroup Inc. raised its holdings in Clover Health Investments by 4,040.8% during the third quarter. Citigroup Inc. now owns 372,421 shares of the company’s stock worth $402,000 after buying an additional 363,427 shares during the last quarter. 19.77% of the stock is owned by institutional investors.

Clover Health Investments Price Performance

Shares of CLOV stock opened at $1.03 on Thursday. The firm has a 50-day moving average of $0.78 and a 200-day moving average of $0.89. The company has a market cap of $511.33 million, a P/E ratio of -3.03 and a beta of 1.88. Clover Health Investments, Corp. has a one year low of $0.61 and a one year high of $1.63.

Clover Health Investments (NASDAQ:CLOVGet Free Report) last announced its earnings results on Tuesday, May 7th. The company reported ($0.05) EPS for the quarter, beating the consensus estimate of ($0.07) by $0.02. The company had revenue of $346.92 million during the quarter, compared to the consensus estimate of $316.10 million. Clover Health Investments had a negative net margin of 8.63% and a negative return on equity of 48.07%. As a group, research analysts expect that Clover Health Investments, Corp. will post -0.21 earnings per share for the current fiscal year.

Insider Activity

In other news, Director Anna U. Loengard bought 137,000 shares of the stock in a transaction dated Thursday, March 14th. The stock was bought at an average price of $0.73 per share, for a total transaction of $100,010.00. Following the completion of the acquisition, the director now directly owns 538,841 shares in the company, valued at approximately $393,353.93. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 22.28% of the stock is currently owned by corporate insiders.

Clover Health Investments Profile

(Free Report)

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.

Further Reading

Institutional Ownership by Quarter for Clover Health Investments (NASDAQ:CLOV)

Receive News & Ratings for Clover Health Investments Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clover Health Investments and related companies with MarketBeat.com's FREE daily email newsletter.